ICON
ICON plc and Medidata have partnered to migrate patient-reported outcome (PRO) instruments from paper to Medidata Patient Cloud, Medidata's mobile app for capturing patient-reported data. This Instrument Library, which follows industry best practices and guidelines, reduces trial costs with productized, cross-platform instruments. ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development—from compound selection to Phase I-IV clinical studies. ICON currently has approximately 11,000 employees, operating in 40 countries.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dental and Oral Health
- Dermatology
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Hepatology
- Immunology
- Infectious Diseases
- Inflammation
- Internal Diseases
- Metabolic Diseases
- Musculoskeletal
- Nephrology
- Neurology
- Nutrition and Health
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology/ENT (Ear/Nose/Throat)
- Pediatrics / Neonatology
- Pharmacology / Toxicology
- Podiatry
- Psychiatry
- Pulmonary
- Respiratory
- Rheumatology
- Sleep
- Surgery
- Thrombosis
- Urology
- Vaccines